You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA-1273.617.2

Showing 1 - 25 of 893
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273.211
  • +6 more
  • Sacramento, California
  • +22 more
Nov 16, 2022

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

Completed
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • Decatur, Georgia
  • +2 more
Jan 26, 2023

SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1283
  • +2 more
  • Chandler, Arizona
  • +4 more
Sep 22, 2022

Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

Completed
  • Healthy
  • Chronic Stable Illness
  • Little Rock, Arkansas
  • +5 more
Jan 9, 2023

Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))

Active, not recruiting
  • Lung Transplant Recipient
  • +2 more
  • mRNA-1273 (Moderna COVID-19 vaccine)
  • Los Angeles, California
    UCLA Clinical Translational Research Center
Dec 13, 2022

COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among

Active, not recruiting
  • Covid19
  • SARS-CoV2 Infection
  • mRNA-1273
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2022

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

COVID-19, COVID-19 Immunisation Trial in United States (mRNA-1273, mRNA-1273.351)

Active, not recruiting
  • COVID-19
  • COVID-19 Immunisation
  • mRNA-1273
  • mRNA-1273.351
  • Decatur, Georgia
  • +3 more
Aug 11, 2022

SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology

Active, not recruiting
  • Covid19
  • Cancer
  • Blood Sample
  • Rochester, New York
    University of Rochester
Sep 6, 2022

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among

Completed
  • SARS-CoV-2
    • New York, New York
      Aetion Inc.
    May 5, 2022

    COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

    Active, not recruiting
    • COVID-19
    • Vienna, Austria
      Medicial University of Vienna
    Apr 12, 2022

    SARS-CoV-2 Trial in United States (mRNA-1273.214)

    Recruiting
    • SARS-CoV-2
    • mRNA-1273.214
    • Montebello, California
    • +6 more
    Jul 28, 2022

    Severe Exacerbation of Severe Acute Respiratory Syndrome

    Active, not recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co. Ltd.,
      Jun 5, 2023

      COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

      Not yet recruiting
      • COVID-19
      • Tozinameran
      • +3 more
      • Melbourne, Victoria, Australia
        Royal Children's Hospital, Murdoch Children's Research Institute
      Sep 14, 2022

      COVID-19 Trial in Jakarta (ABO1009-DP, ABO-CoV.617.2, Placebo)

      Recruiting
      • COVID-19
      • ABO1009-DP
      • +2 more
      • Jakarta, Indonesia
      • +1 more
      Jul 25, 2022

      SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)

      Recruiting
      • SARS-CoV-2
      • +2 more
      • mRNA-1010
      • +4 more
      • DeLand, Florida
      • +29 more
      Jan 23, 2023

      Japan After Severe Acute Respiratory Syndrome Coronavirus 2

      Not yet recruiting
      • SARS-CoV-2
        • Tokyo, Japan
          CMIC Co., Ltd
        Jun 6, 2023

        Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

        Completed
        • Healthy Adult Volunteers
        • ChAdOx1-nCov-19 (Astra-Zeneca)
        • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
        • Taipei City, X, Taiwan
          National Taiwan University Hospital
        Oct 16, 2022

        SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

        Active, not recruiting
        • SARS-CoV-2
        • mRNA-1273
        • Mesa, Arizona
        • +14 more
        Aug 31, 2022

        Infectious Disease, COVID-19 Trial (RVM-V001 10 µg, RVM-V001 30 µg, RVM-V001 60 µg)

        Recruiting
        • Infectious Disease
        • COVID-19
        • RVM-V001 10 µg
        • +2 more
        • Brookvale, New South Wales, Australia
        • +1 more
        Sep 12, 2022

        COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

        Active, not recruiting
        • COVID-19
        • Breakthrough Infection
        • BNT162b2
        • +2 more
        • Taoyuan city, Taiwan
          Chang Gung Memorial Hospital
        Jul 21, 2022

        A Study of the Effectiveness of Moderna COVID-19 Vaccine

        Recruiting
        • SARS-CoV-2
        • COVID-19
        • mRNA-1273
        • Pasadena, California
          Kaiser Permanente Southern California
        Jul 5, 2023

        SARS-CoV-2 Trial in United States (mRNA-1273.214, Placebo)

        Recruiting
        • SARS-CoV-2
        • mRNA-1273.214
        • Placebo
        • Madera, California
        • +21 more
        Jan 11, 2023